Concord Medical Services Holdings Limited (CCM)
Chart Events
Performance Outlook
| Previous Close | 1.9500 |
| Open | 2.0700 |
| Bid | 1.9100 x 38800 |
| Ask | 2.0800 x 900 |
| Day's Range | 1.9500 - 1.9800 |
| 52 Week Range | 1.1500 - 3.4000 |
| Volume | |
| Avg. Volume | 1,624 |
| Market Cap | 84.664M |
| Beta (5Y Monthly) | -0.14 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.5490 |
| Earnings Date | Dec 10, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 23, 2015 |
| 1y Target Est | N/A |
- PR Newswire
Concord Medical Announces Its Subsidiary's Application Filing for Potential Listing on The Stock Exchange of Hong Kong Limited
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that its subsidiary, Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), a company incorporated in China, filed an application (the "Application") to l
- Simply Wall St.
Concord Medical Services Holdings (NYSE:CCM) adds CN¥10.0m to market cap in the past 7 days, though investors from five years ago are still down 62%
This week we saw the Concord Medical Services Holdings Limited ( NYSE:CCM ) share price climb by 17%. But that is...
- PR Newswire
Concord Medical Files 2021 Annual Report on Form 20-F
Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers, premium cancer hospitals, and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 (the "Annual Report") with the U
